Acute intranasal treatment with Nerve Growth Factor limits the onset of traumatic brain injury in young rats.
Luigi ManniEleonora LeottaIlia MollicaAnnalucia SerafinoAnnabella PignataroIllari SalvatoriGiorgio ContiAntonio ChiarettiMarzia SoligoPublished in: British journal of pharmacology (2023)
This work is functional to an initial pre-clinical evaluation of the potential of early intranasal NGF treatment in preventing and limiting the disabling outcomes of TBI, a clinical condition that represents one of the greatest unsolved problems of pediatric neurology.
Keyphrases
- growth factor
- traumatic brain injury
- clinical evaluation
- mental health
- liver failure
- type diabetes
- risk assessment
- metabolic syndrome
- combination therapy
- adipose tissue
- young adults
- replacement therapy
- skeletal muscle
- hepatitis b virus
- severe traumatic brain injury
- climate change
- extracorporeal membrane oxygenation
- insulin resistance
- smoking cessation